These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6774915

  • 21. Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.
    Hulin C, Facon T, Rodon P, Pegourie B, Benboubker L, Doyen C, Dib M, Guillerm G, Salles B, Eschard JP, Lenain P, Casassus P, Azaïs I, Decaux O, Garderet L, Mathiot C, Fontan J, Lafon I, Virion JM, Moreau P.
    J Clin Oncol; 2009 Aug 01; 27(22):3664-70. PubMed ID: 19451428
    [Abstract] [Full Text] [Related]

  • 22. Multiple myeloma management.
    Doll DC, Weiss RB.
    W V Med J; 1977 Jul 01; 73(7):151-5. PubMed ID: 267379
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma.
    Palumbo A, Bertola A, Musto P, Caravita T, Callea V, Nunzi M, Grasso M, Falco P, Cangialosi C, Boccadoro M.
    Cancer; 2005 Oct 01; 104(7):1428-33. PubMed ID: 16116606
    [Abstract] [Full Text] [Related]

  • 25. [Acute leukemia and myeloma].
    Riedler GF, Vorburger E, Maier C.
    Schweiz Med Wochenschr; 1972 Nov 04; 102(44):1592-4. PubMed ID: 4509370
    [No Abstract] [Full Text] [Related]

  • 26. Grand rounds: Multiple myeloma.
    Va Med; 1976 Aug 04; 103(8):585-92. PubMed ID: 983275
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
    Vigneau C, Ardiet C, Bret M, Laville M, Fiere D, Tranchand B, Fouque D.
    J Nephrol; 2002 Aug 04; 15(6):684-9. PubMed ID: 12495285
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Multiple myeloma (author's transl)].
    Nakatsuji T, Matsumoto N, Kaku K, Hiroshige Y, Oda S, Shinohara K, Yaga K, Fujii S, Miwa S, Kamei T, Nagasawa T, Tani S.
    Rinsho Ketsueki; 1980 Mar 04; 21(3):347-55. PubMed ID: 7411874
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treatment options for older myeloma patients. From the Multiple Myeloma Research Foundation.
    Anderson KC, Palumbo A, Multiple Myeloma Research Foundation.
    Oncology (Williston Park); 2005 Apr 04; 19(4):447-50. PubMed ID: 15934516
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Alkeran and multiple myeloma.
    Med Lett Drugs Ther; 1966 Apr 22; 8(8):32. PubMed ID: 5913764
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.